NICOLE BOWMAN: Open Payments
NPI 1225474695 · SHELBYVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,995 in 101 payments from 18 companies in 2025. Trend: 2023 $2,158 · 2024 $2,330 · 2025 $1,995
Food & beverage: $1,944Education: $51
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $404 |
| Verona Pharma, Inc. | 11 | $203 |
| Regeneron Healthcare Solutions, Inc. | 7 | $169 |
| Insmed, Inc. | 13 | $151 |
| GlaxoSmithKline, LLC. | 11 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $133 |
| Grifols USA, LLC | 6 | $123 |
| GENZYME CORPORATION | 6 | $121 |
| HARMONY BIOSCIENCES LLC | 3 | $117 |
| JAZZ PHARMACEUTICALS INC. | 4 | $104 |
Products named: DUPIXENT, TEZSPIRE, Ohtuvayre, Arikayce, GLASSIA, Prolastin-C Liquid, WAKIX, XYWAV.
Industry payments across IN — which companies pay providers there.
